These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 8136044)

  • 1. Fear-potentiated startle: a neural and pharmacological analysis.
    Davis M; Falls WA; Campeau S; Kim M
    Behav Brain Res; 1993 Dec; 58(1-2):175-98. PubMed ID: 8136044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological analysis of fear-potentiated startle.
    Davis M
    Braz J Med Biol Res; 1993 Mar; 26(3):235-60. PubMed ID: 8257926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological and anatomical analysis of fear conditioning using the fear-potentiated startle paradigm.
    Davis M
    Behav Neurosci; 1986 Dec; 100(6):814-24. PubMed ID: 3545257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of subcortical and cortical afferents to the lateral nucleus of the amygdala in fear conditioning measured with fear-potentiated startle in rats trained concurrently with auditory and visual conditioned stimuli.
    Campeau S; Davis M
    J Neurosci; 1995 Mar; 15(3 Pt 2):2312-27. PubMed ID: 7891169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-methyl-D-aspartate lesions of the lateral and basolateral nuclei of the amygdala block fear-potentiated startle and shock sensitization of startle.
    Sananes CB; Davis M
    Behav Neurosci; 1992 Feb; 106(1):72-80. PubMed ID: 1554439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lesions of the central gray block conditioned fear as measured with the potentiated startle paradigm.
    Fendt M; Koch M; Schnitzler HU
    Behav Brain Res; 1996 Jan; 74(1-2):127-34. PubMed ID: 8851921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of the central nucleus and basolateral complex of the amygdala in fear conditioning measured with fear-potentiated startle in rats trained concurrently with auditory and visual conditioned stimuli.
    Campeau S; Davis M
    J Neurosci; 1995 Mar; 15(3 Pt 2):2301-11. PubMed ID: 7891168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neural systems involved in fear and anxiety measured with fear-potentiated startle.
    Davis M
    Am Psychol; 2006 Nov; 61(8):741-756. PubMed ID: 17115806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-amygdala infusion of the N-methyl-D-aspartate receptor antagonist AP5 blocks acquisition but not expression of fear-potentiated startle to an auditory conditioned stimulus.
    Campeau S; Miserendino MJ; Davis M
    Behav Neurosci; 1992 Jun; 106(3):569-574. PubMed ID: 1352104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extinction of fear-potentiated startle: blockade by infusion of an NMDA antagonist into the amygdala.
    Falls WA; Miserendino MJ; Davis M
    J Neurosci; 1992 Mar; 12(3):854-63. PubMed ID: 1347562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of pertussis toxin sensitive G-proteins in conditioned fear-potentiated startle: possible involvement of the amygdala.
    Melia KR; Falls WA; Davis M
    Brain Res; 1992 Jul; 584(1-2):141-8. PubMed ID: 1515934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual pathways involved in fear conditioning measured with fear-potentiated startle: behavioral and anatomic studies.
    Shi C; Davis M
    J Neurosci; 2001 Dec; 21(24):9844-55. PubMed ID: 11739592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lesions of the perirhinal cortex but not of the frontal, medial prefrontal, visual, or insular cortex block fear-potentiated startle using a visual conditioned stimulus.
    Rosen JB; Hitchcock JM; Miserendino MJ; Falls WA; Campeau S; Davis M
    J Neurosci; 1992 Dec; 12(12):4624-33. PubMed ID: 1464761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning and expression.
    Walker DL; Paschall GY; Davis M
    Learn Mem; 2005; 12(2):120-9. PubMed ID: 15774945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear.
    Walker DL; Davis M
    J Neurosci; 1997 Dec; 17(23):9375-83. PubMed ID: 9364083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of septal lesions on fear-potentiated startle, and on the anxiolytic effects of buspirone and diazepam.
    Melia KR; Davis M
    Physiol Behav; 1991 Mar; 49(3):603-11. PubMed ID: 1648244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acoustic startle reflex in rhesus monkeys: a review.
    Davis M; Antoniadis EA; Amaral DG; Winslow JT
    Rev Neurosci; 2008; 19(2-3):171-85. PubMed ID: 18751523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological and anatomical analysis of fear conditioning.
    Davis M
    NIDA Res Monogr; 1990; 97():126-62. PubMed ID: 2247135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fear-potentiated startle using an auditory conditioned stimulus: effect of lesions of the amygdala.
    Hitchcock JM; Davis M
    Physiol Behav; 1987; 39(3):403-8. PubMed ID: 3575483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lesions of the central nucleus of the amygdala block conditioned excitation, but not conditioned inhibition of fear as measured with the fear-potentiated startle effect.
    Falls WA; Davis M
    Behav Neurosci; 1995 Jun; 109(3):379-87. PubMed ID: 7662148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.